Dr. Becker is a neurologist who earned his Medical Degree from Ruprecht Karls University in Heidelberg, Germany in 2001. From 2001 to 2003, he was a Research Assistant in Neuroscience investigating the role of embryonic stem cells in spinal cord injury repair at Washington University School of Medicine in St. Louis, Missouri. At Vanderbilt University Medical Center in Nashville, Tennessee, he completed his residency in Internal Medicine in 2004 and his residency in Neurology in 2007. From there, he completed a year-long fellowship in Spinal Cord Injury Medicine at the Johns Hopkins School of Medicine in Baltimore, MD. Dr. Becker is rated as a Distinguished provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Multiple Sclerosis (MS), Paraplegia, Relapsing Multiple Sclerosis (RMS), and Cerebellar Multiple System Atrophy.

Dr. Cristina L. Sadowsky is an assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include spinal cord injury and paralysis restoration. Dr. Sadowsky is also a founder and the clinical director of the International Center for Spinal Cord Injury at the Kennedy Krieger Institute. This program was built on the philosophy that functional restoration is possible for a long time after an injury, utilizing structured medico-rehabilitative interventions through activity-based restorative therapies (ABRT). She serves as a section editor for Physical Medicine and Rehabilitation Reports and is a recurrent invited reviewer for several peer-reviewed medical journals and government and privately funded competitive grant awards for spinal cord injury related research. Dr. Sadowsky has organized numerous courses and seminars, and has been invited to lecture in different universities and at national and international meetings, such as the American Academy of PM&R, American Spinal Cord Injury Association, International Spinal Cord Society and many more. She has published several manuscripts in highly regarded peer-reviewed journals and chapters in prominent specialty books. Dr. Sadowsky is rated as a Distinguished provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are Paraplegia, Acute Flaccid Myelitis (AFM), Spasticity, Neurogenic Bowel, and Osteotomy.

Dr. Albert Recio is an assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His areas of clinical expertise include spinal cord injury, spasticity management, wound healing, paralysis restoration and aquatics medicine. He is a physician in the paralysis restoration program at the International Center for Spinal Cord Injury at the Kennedy Krieger Institute and medical director for the aquatics medicine program there. Dr. Recio received his medical degree from the Perpetual Help College of Medicine in the Philippines. He began internship training there and completed it at Jackson Park Hospital in Chicago. Dr. Recio did his physical medicine and rehabilitation residency at Spaulding Rehabilitation Hospital, which is associated with Harvard Medical School. He then performed a fellowship in spinal cord injury medicine at University of Washington Medical Center. His research interests include functional electrical stimulation, activity-based restoration therapy and electrical stimulation for wound healing. For more than 15 years, Dr. Recio has been a volunteer physician for medical missions in the Republic of the Philippines. He is a member of the American Paraplegia Society, the Association of Academic Physiatrists, the American Academy of Physical Medicine and Rehabilitation and the International Society of Physical Medicine and Rehabilitation. Dr. Recio is rated as a Distinguished provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Paraplegia, Neurogenic Bowel, Transverse Myelitis, and Spasticity.

Dr. Philippines Cabahug is an assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. Dr. Cabahug completed her residency in physical medicine and rehabilitation at Johns Hopkins and got her clinical fellowship in spinal cord injury medicine at Kennedy Krieger Institute (KKI), where she joined the International Center for Spinal Cord Injury as a full-time physician. Dr. Cabahug has worked on several publications regarding Lean Six Sigma Quality Improvement Project focused on improving discharge paperwork. She is also an online contributor to “PM&R Knowledge Now,” the online resource of the American Academy of Physical Medicine and Rehabilitation. Dr. Cabahug is the director of Musculoskeletal Ultrasound (MSK-US) at KKI. She runs two MSK-US clinics at KKI: a musculoskeletal diagnostic clinic and an ultrasound-guided intrathecal pump access clinic. Dr. Cabahug is rated as a Distinguished provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are Paraplegia, Spasticity, Opisthotonos, and Muscle Spasms.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Advanced provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis.

Dr. Ricardo Roda earned a combined MD/PhD degree from University of Rochester and completed an adult neurology residency, followed by a clinical neuromuscular fellowship at Johns Hopkins University School of Medicine. During residency, Dr. Roda developed a special interest in both auto-immune disorders and genetic disorders. Following residency, he spent three years in neurogenetics branch of National Institute of Neurological Disorders and Stroke (NINDS) working with Dr. Craig Blackstone, focusing on the use of the newer DNA sequencing techniques in genetic diagnosis, and in establishing genotype/phenotype correlations neuromuscular disorders. His current clinical interests include developing testing strategies for undiagnosed genetic disorders and myasthenia gravis. Dr. Roda is rated as an Advanced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Spastic Paraplegia Type 7, Hereditary Spastic Paraparesis, Myasthenia Gravis, and Spastic Paraplegia Type 2.

Dr. R. Samuel Mayer is an associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His clinical interests include complications of critical illness, spine disorders, pain management, disorders of muscle tone and cancer rehabilitation. Dr. Mayer serves as the director of cancer rehabilitation, director of undergraduate medical education and residency program director for the Department of Physical Medicine and Rehabilitation. He graduated from the honors program in medical education at Northwestern University School of Medicine and completed his residency in physical medicine and rehabilitation at Rush Medical College. He was chair of the Committee on Medical Education for the American Medical Student Association while he was a medical student. After completing his residency, he remained on faculty at Rush Medical College, eventually becoming the residency program director and acting chair of the Department of Physical Medicine and Rehabilitation. He joined the Department of Physical Medicine and Rehabilitation at Johns Hopkins in 2001. Dr. Mayer serves as director of the Medical Student Summer Clinical Experience in Physical Medicine and Rehabilitation for the Association of Academic Physiatrists. He is Editor in Chief of Knowledge NOW, the American Academy of Physical Medicine and Rehabilitation's online encyclopedia of the field. In 2014, he was named Distinguished Clinician by the American Academy of Physical Medicine and Rehabilitation. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Pediatric Low-Grade Glioma (pLGG), Hemiplegia, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy.

Dr. Dorianne Feldman is an assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. She focuses on critical care physical medicine and rehabilitation. She combines both her skills as a physical therapist and physiatrist when treating her patients. Dr. Feldman holds B.S. and M.S.P.T. degrees from Boston University, and received her M.D. from the George Washington University School of Medicine. Following medical school, she completed a preliminary year in internal medicine at Mercy Medical Center/University of Maryland and then a residency in physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. She served as chief resident from 2008-2009 for the Department of Physical Medicine and Rehabilitation, and was subsequently appointed as a clinical associate. Dr. Feldman has published extensively, including five chapters in professional books. She has received numerous awards and honors, and was twice the recipient of the Hopkins Healer Award for excellence in patient care during residency. In April 2017, Dr. Feldman was inducted into the Miller-Coulson Academy of Clinical Excellence. Inductees are honored for their professionalism, communication skills, diagnostic prowess, depth of knowledge, ability to negotiate the health care system, passion for patient care and service as a role model to medical trainees. Recent News Articles and Media Coverage Dorianne Feldman, M.D., inducted into Miller-Coulson Academy of Clinical Excellence. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are Stroke, Transverse Myelitis, Paraplegia, and Bursitis.

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Dr. Arun Venkatesan serves as Director of the Johns Hopkins Encephalitis Center, where he directs clinical activities and research. At the center he has developed a multidisciplinary program devoted to optimizing diagnosis and management of patients with infectious and autoimmune encephalitis and understanding mechanisms of disease in order to develop more effective treatments. He also plays an active role in the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers. He received his undergraduate degree in biomedical engineering from the University of California, Berkeley in 1994, followed by a Ph.D. in microbiology and immunology and an M.D. from the University of California, Los Angeles. He completed his residency in neurology and fellowship in neuroinfectious and neuroinflammatory diseases at Johns Hopkins, after which he was appointed to the faculty in the department of neurology in 2007. His laboratory research focuses on defining causes and mechanisms of central nervous system injury in the setting of infection and neuroinflammation, with a goal towards developing protective and regenerative strategies. He has received funding from the National Institutes of Health, Howard Hughes Medical Institute, National Multiple Sclerosis Society, and Maryland Stem Cell Research Fund. Dr. Venkatesan is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Encephalitis, Herpes Simplex Encephalitis, Anti-NMDA Receptor Encephalitis, and Multiple Sclerosis (MS).

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy.

Arens Taga is a neurologist specializing in neuromuscular diseases, with a particular focus on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. His clinical work aims to improve the quality of care for patients with ALS through biomarker-based, precision medicine approaches that refine disease stratification and facilitate more targeted and efficient enrollment in clinical trials. As a clinician-scientist, Dr. Taga uses patient-derived induced pluripotent stem cells to model ALS, uncover novel disease mechanisms and identify therapeutic targets that are translatable to clinical trials. In recognition of his work in ALS, Dr. Taga was awarded the 2025 Richard Olney Clinician Scientist Development Award, which honors early-career physician-scientists dedicated to advancing ALS research. Dr. Taga earned his medical degree from the School of Medicine and Surgery at the University of Parma, Italy, where he also completed his neurology residency. He subsequently trained at The Johns Hopkins University, completing a postdoctoral research fellowship in the neuromuscular division, an internal medicine internship, a neurology residency and a neuromuscular clinical fellowship. Dr. Taga is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Cluster Headache.

Dr. Barañano earned her M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine, where she also completed residencies in pediatrics and neurology, along with a fellowship in neurogenetics at the Kennedy Krieger Institute. Dr. Barañano is an Associate Professor of Clinical Neurology. She specializes in the diagnosis and management of rare neurogenetic disorders. She has a particular interest in the genetic control and function of the cerebellum and expertise in childhood-onset and inherited ataxias. She is a member of the multidisciplinary Fetal Management group and is available for prenatal consultations. Dr. Barañano's research includes collaborative efforts with the Johns Hopkins Department of Genetic Medicine and the Division of Neurogenetics at the Kennedy Krieger Institute. Dr. Baranano is rated as an Experienced provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are Hypotonia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Focal or Multifocal Malformations in Neuronal Migration, and Hereditary Ataxia.

Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins. Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy. Contact for Research Inquiries 600 N. Wolfe Street Meyer 2-147 Baltimore, MD 21287 Phone: (410) 955-9100. Dr. Habela is rated as an Experienced provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Epilepsy, and Endovascular Embolization.

Neurologist Payam Mohassel specializes in myopathies, muscular dystrophies, and other hereditary neuromuscular disorders and is the co-director of the Johns Hopkins Myositis Center. Dr. Mohassel obtained his medical degree from the Johns Hopkins University School of Medicine, where he remained for a medical internship, residency training in neurology, and clinical fellowship training in neuromuscular medicine. He then joined the National Institute of Neurological Disorders and Stroke Neurogenetics branch as a clinical research fellow. Dr. Mohassel’s research focuses on translational studies on neuromuscular disorders, and it spans gene discovery efforts, mechanistic studies to identify therapeutic targets, and early phase interventional clinical trials. Dr. Mohassel is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Hereditary Sensory Neuropathy Type 1 (HSN1), and Hereditary Sensory and Autonomic Neuropathy Type 2.

Dr. Justin McArthur is nationally and internationally recognized for his work in studying the natural history, development and treatment of the neurological complications of HIV/AIDS, multiple sclerosis and other neurological infections and immune-mediated neurological disorders. Dr. McArthur has also developed a technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV and diabetes. Currently his clinical practice includes neuroimmunological disorders including MS, neurological infections, and complex undiagnosed neurological disorders. Dr. McArthur was the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for HIV-associated Cognitive Disorders. The Center is an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. he is also the founding director of the Johns Hopkins Sheikh Khalifa Stroke institute. Dr. McArthur received his medical degree from Guys Hospital Medical School in London, UK. He then completed an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, MD. Dr. McArthur stayed with Johns Hopkins to complete a residency in neurology and achieve his Master's in public health. He is the current Director of the Johns Hopkins Department of Neurology and holds the John W. Griffin Professorship in neurology which was established in 2015 by Jeffrey and Harriet Legum. In April 2017 Dr. McArthur was elected to the Association of American Physicians. In 2020 he was inducted into the National Academy of Medicine. Dr. Mcarthur is rated as an Experienced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Encephalitis.

Travis Edmiston, M.D., is a rehabilitation physician specializing in treating people with spinal cord injuries and dysfunction at the International Center for Spinal Cord Injury at Kennedy Krieger Institute. He uses modern treatment approaches that support all aspects of recovery after a spinal cord injury. Learn about scheduling an appointment with the Center for Spinal Cord Injury. Dr. Edmiston obtained his medical degree from Oregon Health & Science University. He completed his residency in physical medicine and rehabilitation at the Johns Hopkins University School of Medicine, followed by a fellowship in spinal cord injury medicine at Kennedy Krieger Institute and Johns Hopkins. Before joining Johns Hopkins and Kennedy Krieger, Dr. Edmiston worked as an attending physician for the inpatient acute spinal cord injury unit at the Los Angeles County Department of Health Services Rancho Los Amigos National Rehabilitation Center. Dr. Edmiston’s research interests focus on improving recovery and independence for people with spinal cord injury. He has been involved with several quality improvement efforts focused on opioid safety, improving rates of discharge to the community after injury and integrating the multispecialty rehabilitation team earlier into a patient’s hospital care. Dr. Edmiston is rated as an Advanced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Neurogenic Bowel, Paraplegia, Spasticity, and Troyer Syndrome.

Dr. Nancy Yeh is a pediatric physiatrist and the medical director of the Inpatient Rehabilitation Unit at Kennedy Krieger Institute. Dr. Yeh is also an assistant professor of Physical Medicine and Rehabilitation at The Johns Hopkins University School of Medicine. Dr. Yeh received a bachelor’s of science degree from Rice University in Houston, Texas and medical degree from St. George’s University School of Medicine. She completed a residency in physical medicine and rehabilitation at Northwell Health in New York. Following residency, she completed a fellowship in pediatric rehabilitation medicine at Kennedy Krieger Institute and Johns Hopkins University School of Medicine in 2017 and later that year joined the faculty. Selected Publications Yeh, N., Slomine, B.S., Paasch, V. et al. Rehabilitation in Children with Disorder of Consciousness. Curr Phys Med Rehabil Rep 7, 94–103 (2019). Dr. Yeh is rated as an Experienced provider by MediFind in the treatment of Paraplegia. Her top areas of expertise are Cerebral Palsy, Spastic Diplegia Infantile Type, Encephalitis, and Recessive Chondrodysplasia Punctata 1.

Dr. Vinh is no longer accepting new patients. Dr. Vinh is rated as an Advanced provider by MediFind in the treatment of Paraplegia. His top areas of expertise are Paraplegia, Apraxia, Hemiplegia, and Stroke.